title: Main editor's comment to the paper: the response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma. Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek.
authors.affiliation: Institute of Neurosurgery, Catholic University Medical School, Policlinico Gemelli, Largo Gemelli 8, 00186, Rome, Italy, cdirocco@rm.unicatt.it.
authors.forename: Concezio
authors.initials: C
authors.lastname: Di Rocco
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D044482:Benzeneacetamides / Q000009:adverse effects / Q000627:therapeutic use*; D020295:Brain Stem Neoplasms / Q000188:drug therapy* / Q000401:mortality; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D004338:Drug Combinations; D005260:Female; D005910:Glioma / Q000188:drug therapy* / Q000401:mortality; D005973:Glutamine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000401:mortality; D010648:Phenylacetates / Q000009:adverse effects / Q000627:therapeutic use*; D010881:Piperidones / Q000009:adverse effects / Q000627:therapeutic use*; D011149:Pons; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D044482:Benzeneacetamides; D004338:Drug Combinations; D010648:Phenylacetates; D010881:Piperidones; D005973:Glutamine; C092038:antineoplaston AS 2-1; C052091:antineoplaston A10